E-DRUG: USTR Complaints about parallel importing etc

E-drug: Countries where the USTR complains about Parallel Importing,
Compulsory Licensing, and Data Exclusivity
----------------------------------------
[copied from PHARM-POLICY]

Taken from 1999 National Trade Estimate Report on Foreign Trade
Barriers- USTR
http://www.ustr.gov/reports/nte/1999/contents.html

Parallel Importing:
Argentina
Australia
Colombia
Ecuador
European Union
Guatemala
Israel
New Zealand
Norway
South Africa
Venezuela

Compulsory Licensing:
Argentina
Cameroon
Colombia
Dominican Republic
Egypt
El Salvador
Ireland
Guatemala
Saudi Arabia
Honduras
India
Indonesia
Israel
Thailand

Data Exclusivity:
Argentina
Australia
Chile
Ecuador
Korea
Poland
South Africa
Venezuela

----------------------------------------------
-Shivan Mehta, Consumer Project on Technology
shivan.mehta@yale.edu, 202-387-8030
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.